Chinanews, December 30th, a comprehensive report, on the 30th local time, the British government announced that the new crown vaccine developed by Oxford University and British AstraZeneca Pharmaceutical Company has been approved in the UK.
AstraZeneca and other developers said that they are studying the impact of the mutated new coronavirus strain, but expect its vaccination to still be effective.
Data map: On December 8, local time, the United Kingdom began to vaccinate the new crown vaccine. Priority will be given to vaccinations for nursing home staff, people over 80, and front-line medical and social workers before providing other groups of people with vaccination services. The risk of infection determines the order of vaccination.
According to a report by Agence France-Presse, a British government spokesman stated that he had accepted the recommendations of the British Medicines and Healthcare Products Administration (MHRA) to “authorize the use of Oxford University and AstraZeneca's new crown vaccine”, and the UK became the first to approve the The country where the vaccine is put into use.
In addition, the British Broadcasting Corporation (BBC) reported that the UK has ordered 100 million doses of vaccine from AstraZeneca, enough to vaccinate 50 million people.
Recently, the mutated new crown virus found in the UK has attracted attention and is considered to be more infectious.
According to Reuters, AstraZeneca and other developers said they are studying the impact of the mutant new coronavirus strain, but expect its vaccine injection to be effective.
Previously, the British regulatory agency has approved the use of the new crown vaccine developed by the German Biotech Company and Pfizer Pharmaceutical Co., Ltd. of the United States. This is also the first new crown vaccine approved for use in the UK.
The country began to vaccinate the people with the new crown vaccine on December 8.